Medite Cancer Diagnostics Financing
Medite Cancer Diagnostics, Inc., Corporation just filed form D because of $3.00 million equity financing. This is a new filing. Medite Cancer Diagnostics was able to fundraise $400,000 so far. That is 13.33% of the round of financing. The total fundraising amount was $3.00 million. The offering form was filed on 2016-11-02. The reason for the financing was: 7.5% cash commission + 3,000,000 warrants exercisable at .50 per share.. The fundraising still has about $2.60 million more and is not closed yet. We have to wait more to see if the offering will be fully taken.
Medite Cancer Diagnostics is based in Florida. The filler’s business is Other Health Care. The D form was filed by David E Patterson Chief Executive Officer. The company was incorporated more than five years ago. The filler’s address is: 4203 Sw 34Th St, Orlando, Fl, Florida, 32811. David Eugene Patterson is the related person in the form and it has address: 4203 Sw 34Th Street, Orlando, Fl, Florida, 32811. Link to Medite Cancer Diagnostics Filing: 000141588916007327.
Analysis of Medite Cancer Diagnostics Offering
On average, startups in the Other Health Care sector, sell 68.60% of the total offering size. Medite Cancer Diagnostics sold 13.33% of the offering. The financing is still open. The average investment size for companies in the Other Health Care industry is $1.16 million. The offering was 65.52% smaller than the average of $1.16 million. Of course this should not be taken as negative. Startups get financed for a variety of reasons and needs. The minimum investment for this fundraising is set at $50000. If you know more about the reasons for the fundraising, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Medite Cancer Diagnostics Also
The Form D signed by David E Patterson might help Medite Cancer Diagnostics, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.